GO FUND IT NOW

SLOAN-KETTERING INST CAN RESEARCH

Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity

Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity is a funding opportunity from SLOAN-KETTERING INST CAN RESEARCH, up to 1123263, closing August 31, 2027.

Funder
SLOAN-KETTERING INST CAN RESEARCH
Funding
1123263
Deadline
Aug 31, 2027
(396d left)

Overview

PROJECT SUMMARY/ABSTRACT Immunotherapies that boost anti-tumor T cells are landmark breakthroughs in oncology. Yet, current immunotherapies directly activate T cells and are therefore ineffective in ~80% of tumors with few T cells (“cold” tumors). Thus, a primary challenge in oncology is to develop effective…

Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity | Go Fund It Now